Latest technologies from MUSC Foundation for Research Developmenthttp://musc.technologypublisher.comBe the first to know about the latest inventions and technologies available from MUSC Foundation for Research Developmenten-USThu, 23 Nov 2017 01:24:54 GMTMon, 06 Nov 2017 09:53:28 GMThttp://blogs.law.harvard.edu/tech/rsstechnology@musc.eduCopyright 2017, MUSC Foundation for Research DevelopmentChamber for Cyroprotectant Tissues Perfusion and Bioengineered Tissue Scaffoldshttp://musc.technologypublisher.com/technology/26543Mon, 06 Nov 2017 09:53:28 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26543Biopsy Clip Metal Detector to Aid Breast Surgeryhttp://musc.technologypublisher.com/technology/26521Thu, 02 Nov 2017 15:29:13 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26521Dopamine Gene Variants Predict Response to Aripiprazole in Individualshttp://musc.technologypublisher.com/technology/26397Fri, 13 Oct 2017 11:59:25 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26397The Combination of Two Genetic Variants Can Predict Response to Naltrexone in Individuals with Alcohol Use Disorder (AUD)http://musc.technologypublisher.com/technology/26396Technology: Researchers at MUSC have identified multiple gene variants that are critical for the response to opioid receptor antagonists, including naltrexone for AUD. First, recent work has further validated that carriers of OPRM1 asp40/ DAT10 variable number tandem repeat (VNTR) and asn40/ DAT9 variant carriers do better on naltrexone than other treatment groups (figure 1). These results suggest an epistatic balance of the opioid and dopamine systems may exist that should be taken into account in AUD trials.In addition, a single nucleotide polymorphism (SNP) in another functional gene that c...Fri, 13 Oct 2017 09:40:48 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26396Linear Array of Multi-substrate Cell Migration Assay (LAMA)http://musc.technologypublisher.com/technology/26379The invention is a cell migration chamber that allows for multiple substrates to be used in a single assay. The system uses parallel tracks of different substrates and a gap migration technique. This system and method allows for cell adhesion, migration and differentiation on up to 20 different test conditions simultaneously using only minute amounts of target substrata. This system has two configurations for direct comparison of one or two cell type in response to an array of ECM constituents in the same culture conditions. This culture model could also be used for high throughput screening o...Mon, 09 Oct 2017 12:05:20 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26379Total Body Irradiation Using Pre-Existing Dose Dynamic Fieldshttp://musc.technologypublisher.com/technology/26375Technology: TA library of pre-commissioned dose dynamic fields offers a simple method for delivery of total body irradiation (TBI) given in preparation for transplant. This simple technique is available for any VMAT-capable machine, regardless of the treatment room size or span of the MLCs, yet does not require complex planning or patient-specific MLC patterns. Unlike other similar TBI techniques that require whole-body CT scans, this technique can use simple measurements of patient size for treatment planning. The researchers have generated four pre-defined dose dynamic arcs that can produce ...Mon, 09 Oct 2017 05:32:09 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26375Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1- Sickle Cell Diseasehttp://musc.technologypublisher.com/technology/26229Wed, 13 Sep 2017 08:24:46 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26229Mitochondrial targeted HDAC inhibitors for the treatment of heart failure and related diseases and disorders (MitoDACs)http://musc.technologypublisher.com/technology/26069Tue, 22 Aug 2017 05:13:30 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/26069Pharmaceuticaly Modified T cells for Adoptive Cell Therapy Against Cancerhttp://musc.technologypublisher.com/technology/25616Mon, 10 Jul 2017 08:25:00 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25616Antifibrotic effects of oxetanyl sulfoxideshttp://musc.technologypublisher.com/technology/25496Currently, there are only two approved therapies for Idiopathic Pulmonary Fibrosis (IPF), pirfenidone and nintedanib, which are minimally effective at slowing the disease. These treatments are not effective at all in halting or reversing the progression of IPF. Therefore, there remains a great need for more effective therapies. Researchers at MUSC and Pitt have found that a novel compound, MMS-350, can significantly reduce pro-fibrotic factors and ECM proteins both in vitro and in vivo. Figure 1 demonstrates that in bleomycin treated mice oral doses of MMS-350 ameliorates fibrosis histological...Wed, 14 Jun 2017 13:07:25 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25496Detachable Surgical Drainage Systemhttp://musc.technologypublisher.com/technology/25447Wed, 07 Jun 2017 11:12:33 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25447MOBI - E-Learning Mobile Application in the Use of Ambulatory Assistive Deviceshttp://musc.technologypublisher.com/technology/25368Wed, 24 May 2017 10:10:07 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25368<![CDATA[Electrobiome®: Microbial Production of Chemicals & Fuels from CO¬2]]>http://musc.technologypublisher.com/technology/25340Mon, 22 May 2017 09:43:30 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25340Delivery of chemotherapeutics to brain tumorshttp://musc.technologypublisher.com/technology/25300Thu, 18 May 2017 08:16:34 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25300Biotinylated bioluminescent probe (YuLu) for the detection of luciferasehttp://musc.technologypublisher.com/technology/25293The global preclinical imaging market is estimated to reach 910 million in the US alone by 2021, including utilizing bioluminescent probes to study biological processes in vitro and in vivo in real time, image cancer cells, monitor gene delivery and adoptively transferred cells and track pathogen clearance, detect apoptosis and research signal transduction. Current limitations with many bioluminescence probes are the need for an external light source to excite the probe. Lucerifase based probes overcome this issue, however, D-luciferin or other small molecule substrates only last a very short ...Wed, 17 May 2017 07:20:54 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25293 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR)http://musc.technologypublisher.com/technology/25284Tue, 16 May 2017 06:42:33 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25284CD38 mediated metabolic axis in anti-tumor T cell immunotherapyhttp://musc.technologypublisher.com/technology/25278Fri, 12 May 2017 10:17:49 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25278Metrix Matrix: A Novel Cloud-Based System for Tracking Non-RVU Value-Added Work Metricshttp://musc.technologypublisher.com/technology/25077Metrix Matrix is a novel cloud based system used to track value-added non-RVU (vRVU) work metrics with minimal interruption to the radiologist workflow. The password- protected home page for the system contains links to web based forms created using Google Forms, with collected data populating Google Sheets spreadsheets. vRVU metrics initially selected for tracking included time spent at or in preparation for interdisciplinary conferences, time spent on hospital committee meetings, time spent reviewing outside studies (not billed at our institution), and time spent on practice based quality im...Fri, 14 Apr 2017 12:10:35 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25077Improving Tumor Suppression Effects of Cisplatin Utilizing a HPV Derived Peptide for Head and Neck Cancershttp://musc.technologypublisher.com/technology/25063Inventors found that human papillomavirus (HPV) activates a specific protein called E2F5 to improve cell death in HPV(+) head and neck squamous cell carcinoma (HNSCC) cells and tumors in culture and in animals. Using molecular, pharmacologic and genetic tools, the inventors have shown that HPV early protein 7 (E7) enhances ceramide-mediated lethal mitophagy in response to chemotherapy-induced cellular stress in HPV-positive HNSCC cells by selectively targeting retinoblastoma protein (RB). Inhibition of RB by HPV-E7 relieves E2F5, which then associates with DRP1, providing a scaffolding platfor...Tue, 11 Apr 2017 12:18:34 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25063LSD1 Protein Inhibitors as Fetal Hemoglobin Inducers for Sickle Cell Diseasehttp://musc.technologypublisher.com/technology/25012Researchers at MUSC have identified several potential inhibitors of lysine-specific demethylase 1 (LSD1) utilizing a virtual screen, and found compounds that fit the LSD1 active site in silico. Researchers have synthesized these molecules and evaluated them as LSD1 inhibitors, and several compounds inhibit the enzyme with Ki values in the mid-to upper nanomolar range. The series of compounds are new chemical entities and are being developed by structural modification into lead compounds with the goal of developing them as antitumor agents as well as exploring them for sickle cell disease with ...Tue, 04 Apr 2017 04:58:58 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/25012AMBIpack - Ambidextrous Safe Suture Packaginghttp://musc.technologypublisher.com/technology/23924Thu, 02 Feb 2017 12:26:38 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23924Application of GARP antibodies and fusion proteins in cancer, inflammatory and immune conditionshttp://musc.technologypublisher.com/technology/23915Researchers at MUSC have demonstrated that GARP is a novel oncogene due to its cancer-intrinsic roles in promoting invasion and metastasis, as well as its cancer-extrinsic roles in inducing immune tolerance. Administration of a GARP-specific mAb limited metastasis and resulted in an effective cancer therapy in a mouse model of breast cancer (Fig 1). Multiple antibodies and fusion proteins for modulating levels of GARP have been generated and may be useful in treating cancer, acute graft-versus-host disease, transplant rejection, inflammatory conditions and autoimmune diseases. The antibodies c...Wed, 01 Feb 2017 08:44:54 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23915Application of GARP antibodies and fusion proteins in cancer, inflammatory and immune conditionshttp://musc.technologypublisher.com/technology/23914Wed, 01 Feb 2017 08:33:21 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23914Novel class I HDAC inhibitors that are impervious to glucuronidation for the treatment of hematologic malignancies and inflammatory diseases/disordershttp://musc.technologypublisher.com/technology/23912Wed, 01 Feb 2017 07:34:58 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23912<![CDATA[Spinal Implant System for Reduction & Internal Implant Stabilization of Human Spondylolisthesis Deformity]]>http://musc.technologypublisher.com/technology/23584The Hercules spinal implant device and system is to be used for reduction and internal implant stabilization of human vertebral spondylolisthesis deformity. It is a standalone system with unique design that allows an anterior surgical approach to realign and simultaneously stabilize the spinal vertebral segments while protecting and preserve nerve function and not damaging other human body visceral anatomy in order to correct all grades of spondylolisthesis. The proposed solution is to use two implants in the interbody space, allowing greater flexibility to handle high grades of spondylolisthe...Wed, 30 Nov 2016 14:16:50 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23584Targeting CD26hi T-cells for Cancer Therapyhttp://musc.technologypublisher.com/technology/23415Thu, 27 Oct 2016 10:25:02 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/23415Bioremediation of Polychlorinated Biphenyls (PCBs)http://musc.technologypublisher.com/technology/22942Wed, 28 Sep 2016 12:46:14 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22942<![CDATA[Cooperative Therapeutic Effect of Immune Checkpoint Blockade & Anti-sMIC]]>http://musc.technologypublisher.com/technology/22893Fri, 23 Sep 2016 07:52:31 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22893Continuing Medical Education Videoshttp://musc.technologypublisher.com/technology/22759Mon, 29 Aug 2016 13:02:08 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22759Mitoferrofluor - A new approach to determine mitochondrial chelatable ironhttp://musc.technologypublisher.com/technology/22547Tue, 26 Jul 2016 14:39:07 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22547Interprofessionalism (IP) Health-System Simulation Game for Interprofessional Education Initiativeshttp://musc.technologypublisher.com/technology/22497Wed, 20 Jul 2016 11:56:54 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22497 Rib Hook Fixation Devicehttp://musc.technologypublisher.com/technology/22438Wed, 13 Jul 2016 08:23:07 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22438 Monoclonal Antibody for Inhibition of Angiogenesis and Tumor Growthhttp://musc.technologypublisher.com/technology/22094Inventors have generated a monoclonal antibody to TRAF3IP3 that inhibits tumor growth. Inventors discovered that TRAF3IP3 is overexpressed in malignant tumor blood vessels, as well as a panel of tumor cell lines. TRAF3IP3 silenced in angiosarcoma, osteosarcoma, and melanoma inhibit proliferation and increase apoptosis. In vivo, TRAF3IP3 silenced in melanoma inhibits tumor growth by 83% and angiosarcoma growth by 38%. These antibodies block tumor growth and induce apoptosis in in vivo models of melanoma and other cancers. They work by blocking JNK signal transduction pathways that are critical ...Thu, 26 May 2016 12:18:24 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/22094Compound E61 Overcomes Proteasome Inhibitor Resistance in Multiple Myelomahttp://musc.technologypublisher.com/technology/21975Wed, 18 May 2016 11:11:54 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/21975E-learning Mobile Application for Goniometryhttp://musc.technologypublisher.com/technology/21761Inventors at MUSC have developed an interactive, high-quality mobile application for goniometry applicable to physical and occupational therapy. For all upper and lower extremity joint motions, the app provides visual instruction using both labeled pictures and videos. Alternate measurement methods are also included, as are examples of specific precautions, documentation, goal-setting, and functional application. The app is presented in an easy-to-navigate frame with intuitive navigation buttons and is ideal for implementation as a textbook or study aid in physical therapy and occupational the...Fri, 15 Apr 2016 10:59:50 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/21761Immunosuppressive Donor Organ Preservation Solutionhttp://musc.technologypublisher.com/technology/21261Inventors have developed a pH sensitive, targeted micelle nanoparticle for the delivery of immunosuppressive agents directly to a donor organ endothelium prior to transplantation as an additive constituent of standard organ preservation solutions. The device will be engineered in such a way as to enable it to penetrate endothelial cells (ECs) to protect them from ischemia reperfusion injury and also promote endothelial tolerance. In this format, the device is designed so that it can be used in multiple organ preservation solutions, so that it can have a broad application to all solid organ tra...Wed, 20 Jan 2016 10:39:56 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/21261Recombinant Virus to Block Anti-Tumor Immunosuppressionhttp://musc.technologypublisher.com/technology/21243The current invention involves a recombinant myxoma virus which has been engineered to express the extracellular portion of the human PD1 protein from infected cells (vPD1). Soluble PD1 protein binds to the PDL1 on local tumor cells preventing PDL1 from engaging the inhibitory PD1 expressed on tumor infiltration T cells.To date, the inventor has tested the virus as a treatment for subcutaneous melanoma in a preclinical mouse model and it produces ~60% long-term cures, a figure which is outstanding for this model (Fig 1). Moreover, vPD1 is more effective at eradicating melanoma than a Myxoma vi...Thu, 14 Jan 2016 12:47:28 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/21243Method of Enhanced Adoptive Cellular Therapy without Lymphodepletionhttp://musc.technologypublisher.com/technology/20865Fri, 13 Nov 2015 11:24:59 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20865EEGNet: Collaborative Software for EEG Data Review and Annotationhttp://musc.technologypublisher.com/technology/20577Wed, 21 Oct 2015 12:41:07 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20577School Wellness Checklist©http://musc.technologypublisher.com/technology/20552Wed, 14 Oct 2015 10:08:02 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20552 Telehealth Provider Protocolshttp://musc.technologypublisher.com/technology/20388Clinical experts at the Medical University of South Carolina have created protocols as guidelines for treatment by telehealth providers. This telehealth model will require high-definition video conferencing and a suite of diagnostic instruments that provide real-time data to the telehealth provider. These instruments include a digital otoscope and stethoscope. To practice in this telehealth model, providers and telepresenters must meet qualifications established by MUSC. Providers practicing in this model will also be required to participate in a continuing quality assurance program developed ...Thu, 24 Sep 2015 10:07:08 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20388Advanced Electromagnetic Catheter Tracking System for Fluoroscopic and Three-Dimensional Echocardiographyhttp://musc.technologypublisher.com/technology/20237Tue, 08 Sep 2015 09:33:03 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20237Microenvironment Modifying Delivery of Alpha-1-Antitrypsinhttp://musc.technologypublisher.com/technology/20215Inventors are designing a targeted nanocarrier to be used to deliver and protect alpha-1-antitrypsin (A1AT) for the initial therapy of emphysema. The device will be engineered in such a way as to have a protective anti-oxidant coat/shield to prevent the oxidative modification of alpha-1-antitrypsin by the extracellular or intracellular microenvironment. As part of the novel design, A1AT will be contained within a core of a liposome surrounded by an anti-inflammatory therapeutic and coated as described above with an FDA approved anti-oxidant. This technology, while designed specifically for emp...Wed, 02 Sep 2015 14:43:31 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20215Anti-Fibrotic Peptidehttp://musc.technologypublisher.com/technology/20152Tue, 25 Aug 2015 11:03:12 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/20152Processes for Generating Superior Anti-tumor T Cell Effector and Memory Cellshttp://musc.technologypublisher.com/technology/19992Inventors have identified a redox-based strategy to generate, expand, and enable redirection of memory T cells. This strategy promotes higher levels of thiols to generate a therapeutic population of T cells for adoptive T cell therapy. These T cells are not only engineered and ex vivo programmed using a unique cell culture conditions that render them with high anti-oxidant property, but also results in low glycolytic and low mitochondrial membrane potential phenotype, which correlates with a superior ability to control established large tumors. This strategy also shows that tumor epitope react...Wed, 22 Jul 2015 10:27:40 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/19992Synthetic studies toward aza-ellipticine analogs and their potential uses as novel anti-cancer therapeuticshttp://musc.technologypublisher.com/technology/19700Ellipticine is an established anticancer chemotherapeutic, however, its current method of synthesis requires many steps. MUSC researchers have developed a method to obtain ellipticine analogs in one step by utilizing radiation and an acid catalysis. The ellipticine family represents a class of natural products that have been used to develop potential treatments for cancer, HIV, and malarial infection. Recent communications have described rapid access approaches toward quninone4 and aza5 analogs from a common indoline core. Using the MUSC protocol, an alkylated isatin can be derived to form an ...Tue, 02 Jun 2015 09:30:31 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/19700Electrically Conductive Nanomaterials Reinforced Cardiac Microtissueshttp://musc.technologypublisher.com/technology/18715Progenitor cells provide strong regenerative ability, but are limited by their immature phenotype and inability to generate functional tissues equivalent to adult cardiomyocytes. This technology provides a novel approach to successfully regenerate functional cardiomyocytes from progenitor cells. The strategy involves providing a physiologically-relevant microenvironment to develop immature stem cells into functional mature cardiomyocytes by incorporating electrically conductive nanomaterials into a scaffold-free, progenitor cell construct that are intrinsically compatible with catheter-based c...Tue, 24 Mar 2015 11:39:01 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18715Non-Aniline Histone Deacetylase Inhibitorshttp://musc.technologypublisher.com/technology/18710Tue, 24 Mar 2015 09:01:10 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18710MUSC Software Technologieshttp://musc.technologypublisher.com/technology/18281Sat, 14 Feb 2015 14:38:15 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18281<![CDATA[Imaging & Surgical Algorithms]]>http://musc.technologypublisher.com/technology/18280Sat, 14 Feb 2015 14:17:01 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18280MUSC Medical Deviceshttp://musc.technologypublisher.com/technology/18279Sat, 14 Feb 2015 14:05:42 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18279MUSC Diagnostic Technologieshttp://musc.technologypublisher.com/technology/18277Sat, 14 Feb 2015 13:41:12 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18277MUSC Other Therapeuticshttp://musc.technologypublisher.com/technology/18272Fri, 13 Feb 2015 10:18:30 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18272MUSC Neurology Therapeuticshttp://musc.technologypublisher.com/technology/18271MUSC Neurology Therapeutics: Therapeutics for Epilepsy and other Neurological Disordershttp://musc.technologypublisher.com/technology/12246 Compounds for Induction of Mitochondrial Biogenesishttp://musc.technologypublisher.com/technology/12247 Nucleosides Analogs for Cardiovascular and Neurodegenerative Diseaseshttp://musc.technologypublisher.com/technology/10162Fri, 13 Feb 2015 10:05:24 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18271MUSC Oncology Therapeuticshttp://musc.technologypublisher.com/technology/18270MUSC Oncology Therapeutics: Liposomal Delivery of Encapsulated Therapeutics to Treat Pediatric Brain Tumorshttp://musc.technologypublisher.com/technology/17463 LSD1 Protein Inhibitors as Epigenetic Modulatorshttp://musc.technologypublisher.com/technology/15182 Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1 (LSD1)http://musc.technologypublisher.com/technology/15181 Chaperone-based Integrin Inhibitors for the Treatment of Cancer and Inflammatory Diseaseshttp://musc.technologypublisher.com/technology/13451 Antibody Therapeutic for EGFR-expressing Cancershttp://musc.technologypublisher...Fri, 13 Feb 2015 10:05:23 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18270Therapeutic Approach for Combination Cancer Treatments Using Compounds that Block or Interfere with Thromboxane Signaling Pathwayshttp://musc.technologypublisher.com/technology/18269Fri, 13 Feb 2015 09:35:05 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/18269MUSC Fibrosis Therapeuticshttp://musc.technologypublisher.com/technology/18255MUSC Fibrosis Therapeutics Anti-Fibrotic Peptidehttp://musc.technologypublisher.com/technology/15216 A Novel Composition for Wound Healing and Tissue Repairhttp://musc.technologypublisher.com/technology/9562 Peptide for Treatment and Reversal of Fibrosishttp://musc.technologypublisher.com/technology/18231 Cardiac Repair Therapyhttp://musc.technologypublisher.com/technology/6651 Mon, 09 Feb 2015 12:02:12 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/182553-D Biomimetic Technology to Create Defined Architectures in Hydrogelshttp://musc.technologypublisher.com/technology/17788Inventors have developed a biofabrication platform that can be tuned to mimic the native in vivo architecture and geometries vital to the physiological function of tissue. The inventors use a new material for molding intrinsic geometries to an in vitro collagen hydrogel by allowing the adequate transfer of the specific architectural features to a natural scaffold material. The biofabrication platform utilizes state of the art imaging, micromachining, and selective enzymatic activity in order to achieve a new generation of biomaterials for research and clinical applications. The biomaterials ha...Wed, 07 Jan 2015 06:20:40 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17788Research Toolkithttp://musc.technologypublisher.com/technology/17787Wed, 07 Jan 2015 05:30:44 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17787Biomarker panel for Predicting Patient Response to Cardiac Resynchronization Therapyhttp://musc.technologypublisher.com/technology/17411Wed, 22 Oct 2014 06:45:06 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17411Drug Reconstitution and Dilution Compendiumhttp://musc.technologypublisher.com/technology/17341 The Drug Reconstitution and Dilution Compendium is a PDF compendium of dilution information for over 500 drugs. The guidelines for each medication are presented in a standardized format for ease of viewing. References to the primary reference material are provided. This resource serves as a reference tool for pharmacists and technician in pharmacies and hospitals in which reconstitution and/or dilution of medication is performed. The Reconstitution and Dilution Compendium consists of two PDF documents: A Chemotherapy and Hazardous Medication compendium (145 drugs), and a General Reconstituti...Fri, 10 Oct 2014 12:52:15 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17341Postpartum Assessmenthttp://musc.technologypublisher.com/technology/17340Fri, 10 Oct 2014 12:42:44 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17340Newborn Assessmenthttp://musc.technologypublisher.com/technology/17339Fri, 10 Oct 2014 12:41:36 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17339Gross Anatomy Video Serieshttp://musc.technologypublisher.com/technology/17338 The Gross Anatomy Video Series is a series of narrated, demonstrational videos of cadaver dissection meant to supplant instruction during the laboratory component of an anatomy course. The videos can be viewed by students prior to dissection as introductions to the material, or can be used as review tools for content fortification post-dissection. They can also be used by instructors as components of examinations or laboratory practicals. The CDs can also be used by instructors as components of examinations or laboratory practicals. They are available for download as .mp4 video files and can...Fri, 10 Oct 2014 12:25:44 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/17338High-Throughput Screening Assay for Novel Inhibitors of Penicillin Binding Proteinshttp://musc.technologypublisher.com/technology/15981Thu, 25 Sep 2014 10:04:34 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15981Junior Doctors of Health Obesity Prevention Curriculumhttp://musc.technologypublisher.com/technology/15877Tue, 16 Sep 2014 06:49:01 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15877Method of Formalin Fixed Paraffin Embedded Cell Block Preparation of Cytology Specimenshttp://musc.technologypublisher.com/technology/15813Inventors at MUSC have created a straightforward method and apparatus to prepare histologic sections from cytologic specimens (cell block). Cell blocks (CB) are a useful adjunct to other cytopreparatory methods, and when successful, yield multiple histologic sections for subsequent special and immunohistochemical (IHC) staining to classify tumors. In addition, CBs provide lesional cells for molecular diagnostics to determine treatment regimens. The apparatus produces CBs quickly, easily, and inexpensively. The specimen processing is uncomplicated and can be readily implemented into any laborat...Thu, 04 Sep 2014 14:06:12 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15813High-Throughput Screening Assay for Novel Inhibitors of Penicillin Binding Proteinshttp://musc.technologypublisher.com/technology/15236Tue, 20 May 2014 12:43:41 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15236<![CDATA[Pseudo-Diaphragmatic Expansion Perfusion & Cryopreservation of Intact Viable Tissues]]>http://musc.technologypublisher.com/technology/15208Researchers at MUSC have developed a rapid and reproducible method for the cryopreservation of a variety of tissues, such that when thawed are comparable to freshly resected tissues. To date, analysis has been completed on lung tissue from patients undergoing lobectomy or transplant and prostate tissue. This method involves the pseudo-diaphragmatic expansion (rapid and thorough perfusion) of pieces of freshly resected tissue utilizing a universal cryoprotectant (PDX-CP) followed by controlled-rate freezing in cryovials. Expansion-perfusion rates, volumes and the cryoprotectant formulation have...Fri, 16 May 2014 05:47:23 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15208LSD1 Protein Inhibitors as Epigenetic Modulatorshttp://musc.technologypublisher.com/technology/15182Tue, 13 May 2014 06:20:04 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15182Cyclic Peptide Inhibitors of Lysine-Specific Demethylase 1 (LSD1)http://musc.technologypublisher.com/technology/15181Tue, 13 May 2014 06:19:47 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15181Double Pulsed Diffusional Kurtosis Imaginghttp://musc.technologypublisher.com/technology/15000Researchers at MUSC have invented a novel double pulsed diffusion magnetic resonance imaging (dMRI) technique, which is referred to as double pulsed diffusional kurtosis imaging (DP-DKI). The technique is essentially an extension of conventional (single-pulsed) DKI to double pulsed field gradient (d-PFG) sequences. This technique leads to a more efficient and practical double pulsed dMRI method that should substantially increase the potential for applications to the clinical assessment of disease by allowing for the quantification of the non-Gaussian diffusion of water within the brain to help...Tue, 08 Apr 2014 11:00:57 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/15000Advanced White Matter Fiber Tractography Using Non-Gaussian Diffusion MRIhttp://musc.technologypublisher.com/technology/14999A new white matter tractography method based on the dMRI technique of diffusional kurtosis imaging (DKI) has been developed. This method, known as DKI fiber tractography (DKI-FT), substantially improves upon the existing technique because of its ability to resolve intersecting fiber bundles. Moreover, since it is also easily implemented on clinical scanners, DKI-FT is an attractive alternative for clinical applications. Overview: White matter fiber tractography (WMFT) refers to a class of techniques that use data obtained with diffusion magnetic resonance imaging (dMRI) to map axonal fiber bun...Tue, 08 Apr 2014 11:00:56 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/14999Targeted Rapamycin Micelle (TRaM) as a Therapeutic in Solid Organ Transplanthttp://musc.technologypublisher.com/technology/14993Fri, 04 Apr 2014 14:00:56 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/14993MitoMoby Mitochondrial Morphology Analysis Softwarehttp://musc.technologypublisher.com/technology/14779 MitoMoby is a high throughput and high content microscopic method for the analysis of mitochondrial morphology (MM) and membrane potential. MitoMoby delineates a procedure for MM analysis using the R platform for data analysis, annotation, and image registration and GE INCell Investigator (specifically, the GE INCell Developer Toolbox package) platform for image analysis. Video Link: Quantitative Analysis of Mitochondrial Morphology Seven measures of morphological analysis are reported in MitoMoby: total mitochondrial object area (comprised of all phenotypes, representative of total mitochon...Wed, 19 Mar 2014 06:34:20 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/14779DotQuanta Endosome Quantifying Softwarehttp://musc.technologypublisher.com/technology/13663Researchers at MUSC have configured a robust, platform-independent algorithm for use of real-time quantification of receptor endosome formation, agonist mobilization, co-localization, areas, and shapes. The algorithm works by segmenting the cells, localizing fluorescently stained nuclei to the segmented outlines, counting the number of small objects within the cells on 2 wavelengths, and then counting the number of co-localizations between the objects. The algorithm contains several improvements over its first iteration including the ability to select a region of interest of cells, faster perf...Mon, 21 Oct 2013 12:52:02 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/13663Software for Tracking and Invoicing Clinical Researchhttp://musc.technologypublisher.com/technology/12321Fri, 19 Apr 2013 08:07:38 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12321<![CDATA[Services, Pricing & Applications for Research Center (SPARC)]]>http://musc.technologypublisher.com/technology/12320 A request management system for research services, resources and funding opportunities with enterprise-wide and multi-institutional capacity has been developed. As a web-based system, the software creates a consolidated and paperless process for search, requesting and obtaining pricing for research services, allowing researchers to spend less time locating and requesting services and developing a financial plan for their research. The system offers a personalized User Dashboard and Administrator Portal to manage and track their requests. Additionally, service providers are able to manage the...Fri, 19 Apr 2013 08:07:34 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12320Chronic Conditions EHR Problem List Data Dictionaryhttp://musc.technologypublisher.com/technology/12319Fri, 19 Apr 2013 08:07:32 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12319iOS SQL Interfacehttp://musc.technologypublisher.com/technology/12316Fri, 19 Apr 2013 08:07:21 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12316IV Insulin Infusion Calculator with Diagnosis-Specific Modeshttp://musc.technologypublisher.com/technology/12314Fri, 19 Apr 2013 08:06:24 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12314fMRI Based Deception Detectionhttp://musc.technologypublisher.com/technology/12311Fri, 19 Apr 2013 08:05:07 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12311<![CDATA[Electrobiome: Microbial Production of Chemicals & Fuels from Carbon Dioxide]]>http://musc.technologypublisher.com/technology/12257Fri, 29 Mar 2013 12:41:48 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12257iVital: Mobile Monitoring of Anesthesia Information Management Systemshttp://musc.technologypublisher.com/technology/12251Thu, 28 Mar 2013 12:19:27 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12251Therapeutics for Epilepsy and other Neurological Disordershttp://musc.technologypublisher.com/technology/12246Wed, 27 Mar 2013 12:26:08 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/12246Biomarkers for Detecting Diastolic Heart Failurehttp://musc.technologypublisher.com/technology/11928Mon, 25 Feb 2013 10:17:22 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/11928Predicting Left Ventricular Dilation following Myocardial Infarction by Protease and Protease Inhibitor Profilinghttp://musc.technologypublisher.com/technology/11927Mon, 25 Feb 2013 10:17:22 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/11927Biomarkers for Detecting and Monitoring Aortic Aneurysmshttp://musc.technologypublisher.com/technology/11879Mon, 18 Feb 2013 11:24:01 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/11879Bacteriostatic and Anti-Collagenolytic Dental Materialshttp://musc.technologypublisher.com/technology/10154Thu, 30 Aug 2012 09:51:46 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/10154Peptide for Wound Healing and Tissue Repairhttp://musc.technologypublisher.com/technology/9562The inventors have developed a wound-treating material for use in promoting wound healing, decreasing scarring, decreasing inflammation, or promoting formation of healthy tissue architecture post-injury. This JM2 peptide effectively works by blocking hemichannels and lessening ATP release from cells. The JM2 peptide is able to modulate the initial innate immune response to rebuild normal tissue instead of scar tissue. When utilizing the JM2 peptide, there is improved vasculature surrounding an implant capsule with a smaller connective tissue response. This technology has applications in not on...Mon, 18 Jun 2012 11:13:55 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/9562Accurate Lesion Size Measurements during Cardiac Radiofrequency Catheter Ablationhttp://musc.technologypublisher.com/technology/9556 Inventors have developed a radiofrequency ablation (RFA) system, which more accurately estimates lesion size in effort to preserve tissue will be affected during a procedure. The system quantifies blood convection cooling at the cardiac RF catheter ablation site and allows for prediction of lesion size and/or computation of RF energy parameters and characteristics. Overview:With over 400,000 procedures performed worldwide per year (70% in the US), radiofrequency ablation (RFA) is a common, low-invasive procedure used to treat a range of cardiac problems including recurrent atrial flutter, at...Fri, 15 Jun 2012 13:24:08 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/9556Plasma Biomarkers for Predicting Recurrence of Atrial Fibrillation Following Cardioversionhttp://musc.technologypublisher.com/technology/9538Tue, 12 Jun 2012 15:11:06 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/9538Assessing Left Ventricular Remodeling via Temporal Detection and Measurement of microRNA in Body Fluidshttp://musc.technologypublisher.com/technology/9085 This invention provides a method of assessing cardiac disease including thoracic aortic aneurysm (TAA) and left ventricular (LV) remodeling by measuring the levels of 5 microRNAs (miRs) in a body fluid such as plasma or serum, or in cardiac and aortic tissue. miRs are small noncoding RNAs that recognize and bind to mRNA and inhibit protein translation or degrade mRNA. This method allows for the assessment of the risk, development, presence, severity, or a combination, of TAA in the subject. In a separate assay, clinicians can assess the presence and/or severity of LV remodeling post ischemia-...Thu, 08 Mar 2012 06:37:01 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/9085Biomarkers for the Detection and Monitoring of Coronary Artery Diseasehttp://musc.technologypublisher.com/technology/7003Tue, 19 Apr 2011 07:17:30 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/7003Metabolically Stable, Non-Nephrotoxic Puromycin Analogs as Oncology and Anti-infective Therapeuticshttp://musc.technologypublisher.com/technology/6654Sun, 27 Mar 2011 11:06:21 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/6654Biomarker for the Detection and Monitoring of Bladder Cancerhttp://musc.technologypublisher.com/technology/6649Sun, 27 Mar 2011 10:51:25 GMTtechnology@musc.eduhttp://musc.technologypublisher.com/technology/6649